Trial Profile
Phase II study of perioperative S-1 plus docetaxel in patients with localized advanced gastric cancer
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Gastric cancer
- Focus Adverse reactions; Pharmacokinetics
- 28 Jan 2008 New trial record.